| Autor: |
Mahansaria SS; Liver Transplantation & HPB Surgery, Institute of Liver & Biliary Sciences, New Delhi, India., Kumar S; Liver Transplantation & HPB Surgery, Institute of Liver & Biliary Sciences, New Delhi, India., Bharathy KG; Liver Transplantation & HPB Surgery, Institute of Liver & Biliary Sciences, New Delhi, India., Kumar S; Department of Pulmonary Medicine, Institute of Liver & Biliary Sciences, New Delhi, India., Pamecha V; Liver Transplantation & HPB Surgery, Institute of Liver & Biliary Sciences, New Delhi, India. |
| Abstrakt: |
Dyskeratosis congenita is a multisystem genetic disorder. Although hepatic involvement is reported in about 7% of patients with dyskeratosis congenita, it is not well characterized and often attributed to hemochromatosis from frequent blood transfusions. A few case reports describe cirrhosis and hepatic cell necrosis in affected individuals in autosomal dominant pedigrees. Bone marrow failure and malignancies are the principal causes of death in dyskeratosis congenita. We describe the first case of living donor liver transplantation, in dyskeratosis congenita for decompensated cirrhosis with portal hypertension. The patient also had associated severe hepatopulmonary syndrome, interstitial lung disease, bilateral hip replacement for avascular necrosis of the head of femur, and a past history of bone marrow transplantation for bone marrow failure. |
Full Text from ScienceDirect